- DNA As Crystal Ball: Buyer Beware (Newsweek): A genome-wide association study identified a new gene variant associated with Alzheimer’s disease but it turned out clinically it’s not useful.
“Adding these genes to traditional risk factors, such as age and sex, does nothing to aid prediction” of whether someone will develop Alzheimer’s, she told me. “Knowing your genetic status will not help. We may still be in the Stone Age when it comes to gene-based prediction.”
- Breaking: Congress to Investigate DTC Genetic Testing (Genomics Law Report): A really detailed and interesting review.
The United States House of Representatives Committee on Energy and Commerce today launched an investigation into direct-to-consumer (DTC) genetic testing, sending letters to three prominent DTC companies: 23andMe, Pathway Genomics and Navigenics.
- Technology to Print Ingredients Onto Pharma Tablets (Medgadget): Printing of pharmaceutical ingredients directly onto tablets is becoming a reality.
- 23andme: A detailed review of the data the blogger just received from 23andMe.
- Family Spends $200,000 To Have Their Entire Genome Mapped (The Medical Quack)
The family said they received no medical counseling here and are making their own conclusions. One comment made is that the parents stated they will probably be using more pharmaceuticals, interesting.
A patient analyzes her own 23andMe data:
- Sequencing your genome just got cheaper (Genetic Future): The $1000 era is coming fast…
